This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1977 May-Jun;2(3):182-97.

doi: 10.2165/00003088-197702030-00003.

Disease and acetylation polymorphism

P K Lunde, K Frislid, V Hansteen

PMID: 328206
DOI: 10.2165/00003088-197702030-00003

Review

Disease and acetylation polymorphism

P K Lunde et al. Clin Pharmacokinet. 1977 May-Jun.

. 1977 May-Jun;2(3):182-97.

doi: 10.2165/00003088-197702030-00003.

Authors

P K Lunde, K Frislid, V Hansteen

PMID: 328206
DOI: 10.2165/00003088-197702030-00003

No abstract available

PubMed Disclaimer

Similar articles

Clinical consequences of polymorphic acetylation of basic drugs.
Drayer DE, Reidenberg MM. Drayer DE, et al. Clin Pharmacol Ther. 1977 Sep;22(3):251-8. doi: 10.1002/cpt1977223251. Clin Pharmacol Ther. 1977. PMID: 19187
Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW. Clark DW. Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003. Drugs. 1985. PMID: 2859977 Review.
[Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].
Skakun NP. Skakun NP. Klin Med (Mosk). 1982 Jan;60(1):24-7. Klin Med (Mosk). 1982. PMID: 6122757 Review. Russian. No abstract available.
N-acetylation pharmacogenetics.
Weber WW, Hein DW. Weber WW, et al. Pharmacol Rev. 1985 Mar;37(1):25-79. Pharmacol Rev. 1985. PMID: 2860675 Review. No abstract available.
Genetic factors in drug therapy.
Evans DA. Evans DA. Sci Basis Med Annu Rev. 1969:166-82. Sci Basis Med Annu Rev. 1969. PMID: 4918368 Review. No abstract available.

See all similar articles

Cited by

The effect of glucose on acetylation status.
Suhardjono D, Boutagy J, Shenfield GM. Suhardjono D, et al. Br J Clin Pharmacol. 1986 Oct;22(4):401-8. doi: 10.1111/j.1365-2125.1986.tb02909.x. Br J Clin Pharmacol. 1986. PMID: 3768255 Free PMC article.
Polymorphism of carbon oxidation of drugs and clinical implications.
Sloan TP, Mahgoub A, Lancaster R, Idle JR, Smith RL. Sloan TP, et al. Br Med J. 1978 Sep 2;2(6138):655-7. doi: 10.1136/bmj.2.6138.655. Br Med J. 1978. PMID: 151576 Free PMC article.
Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer.
Horai Y, Fujita K, Ishizaki T. Horai Y, et al. Eur J Clin Pharmacol. 1989;37(6):581-7. doi: 10.1007/BF00562549. Eur J Clin Pharmacol. 1989. PMID: 2612554
Acetylation, deacetylation and acyltransfer.
King CM, Glowinski IB. King CM, et al. Environ Health Perspect. 1983 Mar;49:43-50. doi: 10.1289/ehp.834943. Environ Health Perspect. 1983. PMID: 6131820 Free PMC article. Review.
Oxidative activation of proguanil and dapsone acetylation in Thai soldiers.
Edstein MD, Shanks GD, Teja-Isavadharm P, Rieckmann KH, Webster HK. Edstein MD, et al. Br J Clin Pharmacol. 1994 Jan;37(1):67-70. doi: 10.1111/j.1365-2125.1994.tb04241.x. Br J Clin Pharmacol. 1994. PMID: 8148220 Free PMC article.

See all "Cited by" articles

References

1. J Pharm Sci. 1974 Aug;63(8):1191-7 - PubMed
1. Can Med Assoc J. 1963 Dec 14;89:1214-7 - PubMed
1. Prog Liver Dis. 1976;5:259-79 - PubMed
1. Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):433-8 - PubMed
1. Am J Trop Med Hyg. 1974 Mar;23(2):222-30 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.